insights_auto
Why is EMCURE down 2.85%?
Dive Deeperchevron_right
EMCURE:NSE
Emcure Pharmaceuticals Ltd
₹1,768.80
arrow_downward
-2.85%(-51.80) 1D
Oct 19, 3:30:00 PM GMT+5:30 · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EMCURE...
Open
₹1,801.00
High
₹1,829.00
Low
₹1,746.50
Mkt. cap
335.46B
Avg. vol.
174.44K
Volume
108.21K
Dividend
0.20%
Quarterly dividend
₹0.90
Ex-dividend date
Sep 4, 2026
P/E ratio
33.15
52-wk high
₹2,100.70
52-wk low
₹1,306.50
EPS
₹53.35
No. of employees
7K
Open
₹1,801.00
High
₹1,829.00
Low
₹1,746.50
Mkt. cap
335.46B
Avg. vol.
174.44K
Volume
108.21K
Dividend
0.20%
Quarterly dividend
₹0.90
Ex-dividend date
Sep 4, 2026
P/E ratio
33.15
52-wk high
₹2,100.70
52-wk low
₹1,306.50
EPS
₹53.35
No. of employees
7K
News stories
From web sources and news partners
StoneX
·
1 hour ago
Dow Jones Forecast: DJIA falls as AI financing fears and rising oil prices weigh on sentiment
ChartMill
·
1 hour ago
S&P 500 Gap-Down Stocks Fall in October 20, 2026 Session
Yahoo Finance
·
3 hours ago
DOW Gains on Projects & Self-Help Actions Amid Demand and Cost Woes
bloomingbit
·
1 hour ago
U.S. Stocks Turn Higher; Nasdaq Rises 0.52%
Profile
Emcure Pharmaceuticals Limited is an Indian multinational pharmaceutical company, headquartered in Pune. Emcure's product portfolio includes tablets, capsules and injectables. The company produces gynaecology, cardiovascular, oncology and blood therapeutic drugs, HIV antivirals and other anti-infectives, and vitamins and minerals. Wikipedia
About Emcure Pharmaceuticals Ltd
CEOSatish Ramanlal Mehta
Employees6.91K
FoundedApr 16, 1981
Headquarters-
SectorPharmaceutical industry
Websiteemcure.com